| 1 |
Schiff base ligand |
5 |
Copper |
A-549 and HeLa |
Copper complex was more active than complex 5 |
90
|
| 2 |
Macrocyclic ligand |
49 |
Zinc |
HeLa |
Complex 49 was more active than the zinc complex |
161
|
| 3 |
1-[Amino(thioxo)methyl]-5-hydroxy-3-methyl-1H pyrazole |
63 and 64 |
Copper and nickel |
HeLa and K562 |
Complexes 63 and 64 were less active than copper complexes, and had comparable activity to that of nickel complexes |
199
|
| 4 |
Coumarin derivative |
73 |
Manganese, nickel copper and zinc |
MCF-7 and K-562 |
Complex 73 was many folds more active than manganese, nickel, copper and zinc complexes |
221
|
| 5 |
Coumarinyl–pyrazolyl–thiazole thiosemicarbazone |
74 |
Nickel and copper |
HepG2 |
Both nickel and copper complexes were more active than complex 74 |
222
|
| MCF-7 |
| 6 |
Quercetin and diimine as ligands |
101 |
Nickel and copper |
A-549, PC-3, HeLa and MCF-7 |
Copper complexes were more active than 101, but had comparable activity to that of nickel complex |
245
|
| 7 |
Hydrazone of 2-(2-(2,4-dihydroxybenzylidene)hydrazinecarbonyl)pyridine-1-oxide |
128 |
Nickel, copper and zinc |
MDA-MB-231 and SKOV-3 |
Complex 128 was less active than copper complex, however, complex 128 was much more active than nickel and zinc complexes |
73
|
| 8 |
Thio-bis(benzimidazole) |
129 |
Copper and zinc |
CEM, MCF-7, HeLa and G-361 |
Complex 129 was more active than copper and zinc complexes |
39
|
| 9 |
Sodium valproate and 1,10-phenanthroline as ligands |
130 |
Manganese |
HeLa and HepG2 |
Comparable activity |
243
|